Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Batia, Weiss"'
Autor:
Nurit Loberman Nachum, Nir Salomon, Anat Yerushalmy-Feler, Yael Weintraub, Dotan Yogev, Maya Granot, Yael Haberman, Shomron Ben-Horin, Batia Weiss
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundCurcumin and Qing Dai (QD) are herbal extracts that recently showed efficacy in treating inflammatory bowel disease (IBD). Since 2016, a combination of curcumin with QD (CurQD) has been employed in our center for management of active ulcera
Externí odkaz:
https://doaj.org/article/213bd003db4f47878ad1888e5e3b5483
Autor:
Alex Krauthammer, Ilana Weintraub, Ron Shaoul, Raffi Lev-Tzion, Efrat Broide, Michael Wilschanski, Aaron Lerner, Baruch Yerushalmi, Dror S. Shouval, Hussein Shamaly, Yael Haberman-Ziv, Batia Weiss
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
Objective and aimInfantile-onset inflammatory bowel disease (IO-IBD), defined as IBD diagnosed at age 2 years or younger, tends to be more severe and refractory to conventional treatment than IBD diagnosed at a later age. However, data about IO-IBD a
Externí odkaz:
https://doaj.org/article/9aed0ed6d30c4e6e89bd1ca1114c6710
Autor:
Batia Weiss, Shomron Ben-Horin, Atar Lev, Efrat Broide, Miri Yavzori, Adi Lahat, Uri Kopylov, Orit Picard, Rami Eliakim, Yulia Ron, Irit Avni-Biron, Anat Yerushalmy-Feler, Amit Assa, Raz Somech, Ariella Bar-Gil Shitrit
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Background and aimAnti-TNFα is measurable in infants exposed in utero up to 12 months of age. Data about the exposure effect on the infant’s adaptive immunity are limited. We aimed to prospectively evaluate the distribution and function of T and B
Externí odkaz:
https://doaj.org/article/292e3f39f70b4f9e901229da3e826e41
Autor:
Zohar Ben-Shatach, Tomer Ziv-Baran, Ella Fudim, Miri Yavzori, Orit Picard, Asaf Levartovsky, Limor Selinger, Batia Weiss, Uri Kopylov, Rami Eliakim, Bella Ungar
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Higher infliximab trough levels (TLs) correlate with better clinical, inflammatory, and endoscopic outcomes among inflammatory bowel disease (IBD) patients. Although standard scheduled infliximab therapy regimen consists of infusions at p
Externí odkaz:
https://doaj.org/article/5485291456cf4c45a2307114ad38611c
Autor:
Ohad, Atia, Zivia, Shavit-Brunschwig, Diane R, Mould, Ronen, Stein, Manar, Matar, Marina, Aloi, Oren, Ledder, Gili, Focht, Darja, Urlep, Jeffrey, Hyams, Efrat, Broide, Batia, Weiss, Jeremiah, Levine, Richard K, Russell, Dan, Turner
Publikováno v:
The Lancet Gastroenterology & Hepatology. 8:31-42
Scarce data are available on the use of vedolizumab in children with inflammatory bowel disease (IBD). We aimed to evaluate the safety, effectiveness, and dosing of vedolizumab to induce remission of IBD.VEDOKIDS was a paediatric, multicentre, prospe
Autor:
Modi Safra, Lael Werner, Ayelet Peres, Pazit Polak, Naomi Salamon, Michael Schvimer, Batia Weiss, Iris Barshack, Dror S. Shouval, Gur Yaari
Publikováno v:
Genome Research. 33:71-79
Crohn's disease (CD) is a chronic relapsing–remitting inflammatory disorder of the gastrointestinal tract that is characterized by altered innate and adaptive immune function. Although massively parallel sequencing studies of the T cell receptor re
Autor:
Iddo Vardi, Irit Chermesh, Lael Werner, Ortal Barel, Tal Freund, Collin McCourt, Yael Fisher, Marina Pinsker, Elisheva Javasky, Batia Weiss, Gideon Rechavi, David Hagin, Scott B. Snapper, Raz Somech, Liza Konnikova, Dror S. Shouval
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Background: More than 50 different monogenic disorders have been identified as directly causing inflammatory bowel diseases, typically manifesting in the first years of life. We present the clinical course and immunological work-up of an adult patien
Externí odkaz:
https://doaj.org/article/c1e1776f487b4ec2b2d27b4bf92be93e
Autor:
Lael Werner, Yu Nee Lee, Erez Rechavi, Atar Lev, Baruch Yerushalmi, Galina Ling, Neil Shah, Holm H. Uhlig, Batia Weiss, Raz Somech, Scott B. Snapper, Dror S. Shouval
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Patients with loss-of-function mutations in IL10 or IL10 receptor (IL10R) genes develop severe, medical-refractory, infantile-onset inflammatory bowel disease (IBD). We have previously reported significant alterations in innate and adaptive immune re
Externí odkaz:
https://doaj.org/article/73bb68229dc247a8a67ae3b9349d8ec7
Autor:
Alexander Krauthammer, Avishay Lahad, Lior Goldberg, Ifat Sarouk, Batia Weiss, Raz Somech, Michalle Soudack, Itai M. Pessach
Publikováno v:
BMC Pediatrics, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Ataxia telangiectasia (AT) is a rare, multi-systemic, genetic disorder. Mutations in the ATM gene cause dysfunction in cell-cycle, apoptosis and V (D) J recombination leading to neurodegeneration, cellular, humoral immunodeficienc
Externí odkaz:
https://doaj.org/article/c703a2439f5c4d06bcbb3c329bba3cee
Autor:
Tzipi Braun, Ayelet Di Segni, Marina BenShoshan, Roy Asaf, James E. Squires, Sarit Farage Barhom, Efrat Glick Saar, Karen Cesarkas, Gill Smollan, Batia Weiss, Sharon Amit, Nathan Keller, Yael Haberman
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Hospitalized patients are at increased risk for acquiring healthcare-associated infections (HAIs) and inadequate nutrition. The human intestinal microbiota plays vital functions in nutrient supply and protection from pathogens, yet character
Externí odkaz:
https://doaj.org/article/f5d1fc4fe5854d268cfc020dd2a5f79a